Estimating the budget impact of orphan drugs in Sweden and France 2013–2020

BACKGROUND: The growth in expenditure on orphan medicinal products (OMP) across Europe has been identified as a concern. Estimates of future expenditure in Europe have suggested that OMPs could account for a significant proportion of total pharmaceutical expenditure in some countries, but few of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hutchings, Adam, Schey, Carina, Dutton, Richard, Achana, Felix, Antonov, Karolina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930763/
https://www.ncbi.nlm.nih.gov/pubmed/24524281
http://dx.doi.org/10.1186/1750-1172-9-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930763/
https://www.ncbi.nlm.nih.gov/pubmed/24524281
http://dx.doi.org/10.1186/1750-1172-9-22

Ejemplares similares